Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

[RESEARCH PROGRESS OF ADIPOSE-DERIVED STEM CELLS COMPOUND WITH THREE DIMENSIONAL PRINTING SCAFFOLD FOR ENGINEERED TISSUE].

Wang Z., Tian X., Bai S.

Narrative Review, published in Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2016)
Country
China
Reported sample size
—
Source database
PubMed
PMID
27281877

Abstract (original English)

Objective To review the research progress of adipose-derived stem cells (ADSCs) compound with three dimensional (3D) printing scaffold in tissue engineering of fat, bone, cartilage, blood vessel, hepatocyte, and so on. Methods The recently published literature about ADSCs compound with 3D printing scaffold in tissue engineering at home and abroad was reviewed, analyzed, and summarized. Results A large number of basic researches showed that ADSCs could differentiate into a variety of tissues on 3D printing scaffold and involve in tissue repair and regeneration. But there is still a long way between the basic theory and the clinical practice at the early stages of development. Conclusion It can effectively improve and restore the structure and function of the damaged tissue and organ to use ADSCs and 3D printing scaffold.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose TissueCell DifferentiationHumansPrinting, Three-DimensionalRegenerationStem CellsTissue EngineeringTissue Scaffolds

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.